Catalog No.
RHB94601
Species reactivity
Human
Host species
Mouse
Isotype
IgG1
Clonality
Monoclonal
Tested applications
WB: 1:500-1:1000
Target
Interferon alpha-2, IFNA2C, IFNA2, IFN-alpha-2, LeIF A, IFNA2A, IFNA2B, Interferon alpha-A
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P01563
Applications
WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% Sodium Azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
R2X43
Cytokine profiling in COVID-19 patients by using ion mobility-mass spectrometry-based parallel reaction monitoring., PMID:40480698
Salmonid Double-stranded RNA-Dependent Protein Kinase Activates Apoptosis and Inhibits Protein Synthesis., PMID:39058317
More rapid blood interferon α2 decline in fatal versus surviving COVID-19 patients., PMID:38077399
Differential regulation of the interferon response in systemic lupus erythematosus distinguishes patients of Asian ancestry., PMID:37709528
Human genetic diversity regulating the TLR10/TLR1/TLR6 locus confers increased cytokines in response to Chlamydia trachomatis., PMID:35047856
IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals., PMID:33837219
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine., PMID:33544838
An immune-based biomarker signature is associated with mortality in COVID-19 patients., PMID:33232303
Serum interferon levels associated with the disease activity in women with overt Graves' disease., PMID:33121876
Early type I IFN blockade improves the efficacy of viral vaccines., PMID:32820330
Biologic therapy for Behçet's uveitis: a systematic review., PMID:31676596
Bevacizumab plus IFN-alpha-2a in First-line Treatment of Patients With Advanced or Metastatic Renal Cell Carcinoma: A Prospective German Non-interventional Study., PMID:30711970
Rituximab, interferon-alfa-2b and dose dense CVP is highly efficient in patients with FLIPI ≥ 2 follicular lymphoma. Final results of the LNH-PRO-05 study., PMID:30656671
Dysregulation of miR-155-5p and miR-200-3p and the Anti-Non-Bilayer Phospholipid Arrangement Antibodies Favor the Development of Lupus in Three Novel Murine Lupus Models., PMID:29349090
Integrity of a HPV11 infection cell model and identification of (-)-Epigallocatechin-3-gallate as a potential HPV11 inhibitor., PMID:27175598
Increased binding of circulating systemic lupus erythematosus autoantibodies to recombinant interferon alpha 2b., PMID:26547367
Endotoxin tolerance in monocytes can be mitigated by α2-interferon., PMID:26206900
Structural basis of the broadly neutralizing anti-interferon-α antibody rontalizumab., PMID:26099203
RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon α-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma., PMID:25851632
Antimicrobial preservatives induce aggregation of interferon alpha-2a: the order in which preservatives induce protein aggregation is independent of the protein., PMID:24974985
High efficiency cell-specific targeting of cytokine activity., PMID:24398568
44-plex cytokine profile of cholesteatoma., PMID:24256045
Anti-IFN autoantibodies are present in healthy Egyptian blood donors at low titer., PMID:21872225
An antiserum against Atlantic salmon IFNa1 detects IFN and neutralizes antiviral activity produced by poly I:C stimulated cells., PMID:19063917
Characterization of antihuman IFNAR-1 monoclonal antibodies: epitope localization and functional analysis., PMID:10048764
For research use only. Not for human or drug use.
